Brain neoplasm and Weight decreased

Summary:

Weight decreased is found among people with Brain neoplasm, especially for people who are female, 60+ old.

The study analyzes which people have Weight decreased with Brain neoplasm. It is created by eHealthMe based on reports of 72 people who have Brain neoplasm from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Brain neoplasm?

Brain neoplasm (tumour of brain) is found to be associated with 695 drugs and 653 conditions by eHealthMe. Check the latest studies of Brain neoplasm.

What is Weight decreased?

Weight decreased is found to be associated with 3,393 drugs and 4,746 conditions by eHealthMe. Check the latest studies of Weight decreased.



On Jul, 17, 2026

72 people who have Brain Neoplasm and Weight Decreased are studied.

Would you have Weight decreased when you have Brain neoplasm?

Gender of people who have Brain Neoplasm and experienced Weight Decreased *:

  • female: 65.71 %
  • male: 34.29 %

Age of people who have Brain Neoplasm and experienced Weight Decreased *:

  • 0-1: 1.92 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 3.85 %
  • 30-39: 7.69 %
  • 40-49: 15.38 %
  • 50-59: 17.31 %
  • 60+: 53.85 %

Common co-existing conditions for these people *:

  1. Urinary Tract Infection: 15 people, 20.83%
  2. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 15 people, 20.83%
  3. Iron Overload: 15 people, 20.83%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 8.33%
  5. Colitis (inflammation of colon): 6 people, 8.33%
  6. Prolactin-Producing Pituitary Tumor: 5 people, 6.94%
  7. Hyperthyroidism (over activity of the thyroid gland): 5 people, 6.94%
  8. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 5.56%
  9. High Blood Pressure: 4 people, 5.56%
  10. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 4 people, 5.56%

Common drugs taken by these people *:

  1. Exjade: 15 people, 20.83%
  2. Celexa: 15 people, 20.83%
  3. Ditropan: 15 people, 20.83%
  4. Keppra: 11 people, 15.28%
  5. Lasix: 9 people, 12.50%
  6. Dilantin: 8 people, 11.11%
  7. Dexamethasone: 7 people, 9.72%
  8. Magnesium: 7 people, 9.72%
  9. Synthroid: 7 people, 9.72%
  10. Jadenu: 6 people, 8.33%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 31 people, 43.06%
  2. Diarrhea: 28 people, 38.89%
  3. Drug Ineffective: 25 people, 34.72%
  4. Nausea (feeling of having an urge to vomit): 17 people, 23.61%
  5. Urinary Tract Infection: 16 people, 22.22%
  6. Drug Intolerance (drug sensitivity): 16 people, 22.22%
  7. Nausea And Vomiting: 16 people, 22.22%
  8. Dizziness: 15 people, 20.83%
  9. Pain Of Skin: 15 people, 20.83%
  10. Blood Iron Increased: 15 people, 20.83%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Weight decreased:

All the conditions that are associated with Weight decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weight decreased and Brain neoplasm, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: